ArticleOPEN ACCESS

Haplo-BMT: Which approach?

Blood
DOI: 10.1182/blood-2012-12-469981
17Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In patients with hematologic malignancies, Di Bartolomeo et al report encouraging outcomes after transplantation of granulocyte-colony stimulating factor (G-CSF)-primed unmanipulated bone marrow from human leukocyte antigen (HLA)-haplotype mismatched (haploidentical) related donors, suggesting that this procedure makes haploidentical transplantation available in all transplant centers. Copyright © 2011 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Velardi, A. (2013, January 31). Haplo-BMT: Which approach? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-12-469981

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free